Antibiotics for treating osteomyelitis in people with sickle cell disease (Q24241588)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Antibiotics for treating osteomyelitis in people with sickle cell disease (English)

0 references

0 references

1 reference

Arturo J Martí-Carvajal

series ordinal

1

0 references

author name string

Luis H Agreda-Pérez

series ordinal

2

0 references

publication date

15 April 2009

0 references

published in

0 references

cites work

Locations of osteomyelitis in children with sickle-cell disease at Tokoin teaching hospital (Togo).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Sickle cell disease in children: differentiating osteomyelitis from vaso-occlusive crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Septic arthritis in adults with sickle cell disease often is associated with osteomyelitis or osteonecrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Sickle cell anemia and vascular dysfunction: the nitric oxide connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Evidence for HLA class II susceptible and protective haplotypes for osteomyelitis in pediatric patients with sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Bone involvement in sickle cell disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Redox-dependent impairment of vascular function in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Infection in sickle cell disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Severe sickle cell disease--pathophysiology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Etiology of osteomyelitis complicating sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Musculoskeletal manifestations of sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

What is "quality of evidence" and why is it important to clinicians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Shorter courses of parenteral antibiotic therapy do not appear to influence response rates for children with acute hematogenous osteomyelitis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Sickle cell disease and nitric oxide: a paradigm shift?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Diagnosis and management of sickle cell disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Acute clinical events in 299 homozygous sickle cell patients living in France. French Study Group on Sickle Cell Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Sickle cell anemia, a molecular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

The emerging understanding of sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

One hundred years of sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Infection and musculoskeletal conditions: Osteomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Pathophysiologically based drug treatment of sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Hyposplenism: a comprehensive review. Part I: basic concepts and causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Positron emission tomography scans for distinguishing between osteomyelitis and infarction in sickle cell disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Sickle cell disease vasculopathy: a state of nitric oxide resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

7 January 2021

Sickle cell anemia in Guadeloupean children: pattern and prevalence of acute clinical events

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

7 January 2021

Sickle Cell Disease at 100 Years

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

7 January 2021

Differentiation between bone infarction and acute osteomyelitis in children with sickle-cell disease with use of sequential radionuclide bone-marrow and bone scans

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

7 January 2021

Sickle cell disease: selected aspects of pathophysiology.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

7 January 2021

Multidisciplinary management of orthopedic patients with sickle cell disease.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007175.PUB2

7 January 2021